DLD Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

DLD Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-525,000	Closed	-$1.6M	–	107
2019 Q3	$1.6M	Hold	525,000	–	–	0.08%	58
2019 Q2	$1.25M	Buy	525,000 +225,000	+75%	+$672K	0.05%	67
2019 Q1	$1.13M	Hold	300,000	–	–	0.04%	82
2018 Q4	$1.08M	Buy	+300,000	New	+$1.3M	0.07%	65
2017 Q2	–	Sell	-77,800	Closed	-$385K	–	106
2017 Q1	$385K	Buy	+77,800	New	+$749K	0.06%	47

Other funds holding FOMX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

DLD Asset Management's FOMX Position: Q4 2019 in Review

DLD Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 525,000 shares — an estimated $1.6M sold.

DLD Asset Management first reported a position in FOMX in Q1 2017 and held it in 5 quarters. The position peaked at $1.6M in Q3 2019. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

DLD Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
DLD Asset Management sold 525,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $1.6M.
DLD Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2017 and held it in 5 quarters.
DLD Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.6M in Q3 2019.
65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.